Company News

FTC’s Final Order in Deceptive Advertising of Anti-Aging Skin Care

Says TA Sciences lacked scientific evidence to support claims for topical TA-65 for Skin, TA-65MD capsule/powder.

Author Image

By: Christine Esposito

Editor-in-Chief

Following a public comment period, the Federal Trade Commission has approved a final consent order settling deceptive advertising charges against Telomerase Activation Sciences, Inc. and Noel Patton (collectively, TA Sciences).   According to the FTC’s February 2018 complaint, TA Sciences lacked the scientific evidence to support claims that its capsules, powder, and cream could provide a broad range of anti-aging and other health benefits. The complaint specifically addressed allegedly decept...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters